<HashMap><database>ENA</database><scores/><additional><omics_type>Genomics</omics_type><center_name>NYU Langone Health</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJNA1162859</full_dataset_link><scientific_name>Homo sapiens</scientific_name><long_description>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with a hyperreactive platelet phenotype, which is thought to contribute to the high incidence of thrombosis in COVID-19 patients. Mutations of SARS-CoV-2 resulted in several virus variants with differences in transmissibility, infectivity and mortality. This study was designed to investigate how SARS-CoV-2 variants of concern, delta and omicron, affect the transcriptome and function of megakaryocytes (MKs) relative to the ancestral WA1 strain. Overall design: Human CD34+-derived megakaryocytes from 4 unvaccinated COVID-19 donors were infected with WA1, Delta or Omicron SARS-CoV-2 variants or vehicle control for 24 hours.</long_description><repository>ENA</repository></additional><is_claimable>false</is_claimable><name>Effects of Ancestral SARS-CoV-2 versus Variants of Concern Delta and Omicron on Megakaryocyte Activation and Transcriptome</name><description>Effects of Ancestral SARS-CoV-2 versus Variants of Concern Delta and Omicron on Megakaryocyte Activation and Transcriptome</description><dates><last_updated>2025-09-24</last_updated><first_public>2025-09-08</first_public></dates><accession>PRJNA1162859</accession><cross_references><GEO>GSE277576</GEO><taxon>9606</taxon></cross_references></HashMap>